CR consists of a wide-ranging set of health-promoting interventions that include exercise training, dietary counseling, risk factor control, smoking cessation, adherence to therapy and psychosocial support, usually on an outpatient basis. 4 Its benefits in coronary artery disease are well established. In a meta-analysis of 14 486 participants in 63 studies with a median follow-up of 12 months, CR led to reductions of 26% in cardiovascular mortality and 18% in the risk of hospital admissions. 5 This impact on the natural history of coronary atherothrombosis is due to the protective effects of exercise on lipid profile, blood pressure, inflammation and thrombogenic potential. 6 Despite their demonstrated and extensive benefits, 5, 7 exercise-based CR programs are clearly underused, due ଝ Please cite this article as: Ferreira J. Referenciar ou não referenciar para reabilitação cardíaca após síndroma coronária aguda. Rev Port Cardiol. 2017;36:177---178.
E-mail address: jorge ferreira@netcabo.pt to patient-related, physician-related and health systemrelated factors. 8 In their study published in this issue of the Journal, Aguiar Rosa et al. assessed the predictors of improved functional capacity in 129 patients who participated in a CR program following ACS and who underwent cardiopulmonary exercise testing (CPET) at baseline and after 36 exercise training sessions. 9 Among CPET parameters, peak oxygen uptake (pVO 2 ) <20 ml/kg/min compared to pVO 2 ≥20 ml/kg/min was associated with a significantly greater range of improvement in pVO 2 (+4.4 vs. +1.6; p=0.018), in percentage of predicted pVO 2 (+17.9% vs. +4.0%; p=0.009) and in pVO 2 times systolic pressure at peak exercise (+883.3 vs. 238.5 mmHg.ml/kg/min; p=0.015) between baseline and after CR. Depressed or moderately impaired left ventricular ejection fraction was not associated with greater benefit from CR as assessed by improvement in functional capacity.
The rate of recurrence of major vascular events was low in a mean follow-up of five years, with annual mortality of 0.9% and annual ACS incidence of 1.2%. This may be explained by the good adherence to medical therapy, control of risk factors and adoption of healthier lifestyles in the study population.
The authors conclude that patients with poor functional capacity identified by CPET, which in their study represented 25% of a heterogeneous group of patients with ACS, will obtain the greatest benefit from CR. A referral strategy based on this parameter could help optimize use of CR facilities, which are in relatively short supply in Portugal.
